Roche breast cancer drug extends overall survival

ZURICH |
Sat Dec 8, 2012 3:44am EST

ZURICH (Reuters) – Swiss pharma organisation Roche’s drug Perjeta significantly extended a lives of women with an assertive and incorrigible form of breast cancer compared to a placebo, according to new information from a late-stage investigate presented on Saturday.

The minute information presented during a San Antonio Breast Cancer Symposium found that a risk of genocide was reduced by 34 percent in women treated with a multiple diagnosis of a drugs Perjeta and Herceptin and chemotherapy compared to women treated with Herceptin, chemotherapy and a

Read full article: http://www.telegraph.co.uk/news/uknews/crime/9416254/Immigrant-in-Britain-helped-plot-attack-on-Christmas-shoppers.html

Related Posts

• Roche breast cancer drug extends overall survival
• Egypt’s antithesis evade Morsi’s offer of talks as protests swell
• Low seductiveness rate hijacks US banks
• Hugh Jackman still eyes 007 role
• Food manufacturers forced to infer claims of health benefits
• Consumer advocates hearten COAG energy cost plan
• Kate’s pranked helper found dead
• Supreme Court to Take Up Gay Marriage
• Egypt’s antithesis defies call for dialogue, marches on presidential palace
• Payrolls in US Rise Jobless Rate Falls

Source:
http://www.ezonearticle.com/2012/12/08/roche-breast-cancer-drug-extends-overall-survival/